Thymosin alpha-1 bioavailability reaches 80-90% via subcutaneous injection but drops

Animal models show immune modulation in 72 hours; human trials

Thymalin works by delivering short peptide chains that bind thymic

Thymalin receptor pharmacology centers on TLR modulation and thymic peptide

The thymalin signaling pathway regulates T-cell maturation through thymic peptide

Thymosin alpha-1 gene expression regulates immune function through TMSB4X transcription,

Thymalin activates CD4+ T-cells and stimulates IL-2 production within 48–72

Thymalin’s half-life spans 3–4 hours with rapid clearance. Intramuscular absorption

Pinealon metabolism research reveals unique peptide behavior at the cellular

Epithalon receptor pharmacology centers on telomerase activation through pineal peptide

Epithalon activates telomerase via pineal-hypothalamic-pituitary regulation, extending cellular replication cycles

Epithalon activates telomerase through pineal gland pathways, extending telomeres by

Epithalon pharmacokinetics: half-life under 90 minutes, synthetic peptide form reaches

Epithalon activates telomerase and modulates pineal melatonin synthesis, triggering downstream

Epithalon biomarkers track telomere length, melatonin, cortisol, and oxidative stress

Epithalon animal studies show 30–40% lifespan extension, but human research

Epithalon activates telomerase and regulates over 70 genes tied to

Epithalon bioavailability reaches 40–60% via subcutaneous injection but drops below

FOXO4-DRI disrupts p53-FOXO4 protein binding in senescent cells, triggering apoptosis

FOXO4-DRI disrupts the FOXO4-p53 protein complex in senescent cells, restoring

FOXO4-DRI disrupts the FOXO4-p53 protein interaction, selectively targeting senescent cells